Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a smartwatch to diagnose postoperative atrial fibrillation

Official title: Diagnosis of Postoperative Atrial Fibrillation After Cardiac Surgery by a Smartwatch: an Open-label Randomized Controlled Trial

Run by Centre Hospitalier Universitaire, Amiens · NCT05573633 · Data updated 2026-11-12

This study is testing whether a smartwatch can help doctors find out if patients who just had heart surgery develop a common heart rhythm problem called atrial fibrillation while they are still in the hospital.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment324 (estimated)
SponsorCentre Hospitalier Universitaire, Amiens
Academic / other
Locations1 site (Amiens)
StatusRecruiting
StartedOctober 6, 2022
Main results expectedOctober 6, 2027
Study endsJuly 6, 2028
Registry record updatedFebruary 24, 2026
Trial IDNCT05573633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who have undergone recent on-pump cardiac surgery at Amiens University Hospital.

Probably not a fit

Patients with a history of atrial fibrillation or those requiring intensive rhythmic monitoring due to other cardiac conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to diagnose postoperative atrial fibrillation (POAF) in patients who have recently undergone on-pump cardiac surgery using a smartwatch equipped with ECG capabilities. Given that POAF can often be asymptomatic and occurs primarily during hospitalization, the smartwatch will provide continuous heart rate monitoring to detect episodes of POAF early. The study will involve adult patients hospitalized at Amiens University Hospital, who will be monitored for signs of atrial fibrillation within 96 hours post-surgery. The goal is to improve early detection and management of POAF, potentially reducing associated risks and complications.

Why it matters

Potential benefit: If successful, this approach could lead to earlier diagnosis and management of postoperative atrial fibrillation, reducing the risk of serious complications.

How similar studies have gone: While the use of smartwatches for health monitoring is gaining traction, this specific approach to diagnosing POAF post-surgery is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient (\>18 years old)
* The patient was hospitalized at Amiens University Hospital for on-pump cardiac surgery.
* The patient has had a recent on-pump cardiac surgery (\< 96h)
* Patient with the motor and cognitive abilities to perform a 1-lead ECG with the smartwatch
* The patient was transferred to the cardiac surgery department of Amiens University Hospital.
* The beneficiary of a social security plan
* Signature of the consent to participate in the study

Exclusion Criteria:

* History of AF
* Need for rhythmic monitoring by telemetry in cardiac intensive care for atrioventricular block and rapid supra and ventricular rhythm disorder (\>140 bpm).
* An external pacemaker connected to epicardial electrodes depends on ventricular and atrial pacing.
* Patients already included in an interventional clinical research protocol may alter the incidence of POAF.
* Pregnant woman

Where it's running

  • CHU Amiens Picardie
    Amiens, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.